These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 3552792

  • 1. Reduced urinary insulin clearance in patient with abnormal insulinemia.
    Yamamoto R, Iwamoto Y, Sakura H, Yoshioka N, Hsieh SD, Matsuda A, Kuzuya T.
    Diabetes; 1987 May; 36(5):602-6. PubMed ID: 3552792
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Abnormal insulinemia.
    Nanjo K, Kondo M, Sanke T, Nishi M.
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S135-41. PubMed ID: 7859595
    [Abstract] [Full Text] [Related]

  • 4. [Insulinemia--a marker of early diagnosis and control of efficacy of treatment of type II diabetes].
    Szybiński Z, Szurkowska M.
    Pol Arch Med Wewn; 2001 Sep; 106(3):793-800. PubMed ID: 11928588
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Methods for concentration of urinary immunoreactive insulin.
    Du BH, Eng J, Yalow RS.
    J Korean Med Sci; 1986 Sep; 1(1):1-4. PubMed ID: 3077602
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Familial hyperinsulinemia due to a structurally abnormal insulin. Definition of an emerging new clinical syndrome.
    Haneda M, Polonsky KS, Bergenstal RM, Jaspan JB, Shoelson SE, Blix PM, Chan SJ, Kwok SC, Wishner WB, Zeidler A.
    N Engl J Med; 1984 May 17; 310(20):1288-94. PubMed ID: 6371526
    [Abstract] [Full Text] [Related]

  • 11. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C, Ramachandran A, Satyavani K, Latha E, Viswanathan V.
    Diabetes Care; 1998 Jan 17; 21(1):76-9. PubMed ID: 9538973
    [Abstract] [Full Text] [Related]

  • 12. [Residual hyperinsulinism after glucose oral load in obese subjects with normal glucose tolerance].
    Sinagra D, Randazzo C, Galluzzo G, Mistretta A.
    Minerva Endocrinol; 1990 Jan 17; 15(3):203-5. PubMed ID: 2101438
    [Abstract] [Full Text] [Related]

  • 13. Estimation of the secretion rate of insulin from the urinary excretion rate of C-peptide. Study in obese and diabetic subjects.
    Meistas MT, Rendell M, Margolis S, Kowarski AA.
    Diabetes; 1982 May 17; 31(5 Pt 1):449-53. PubMed ID: 6759260
    [Abstract] [Full Text] [Related]

  • 14. Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients.
    Osei K, Falko JM, O'Dorisio TM, Adam DR.
    Diabetes Care; 1984 May 17; 7(5):471-5. PubMed ID: 6389061
    [Abstract] [Full Text] [Related]

  • 15. The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.
    Anderwald C, Anderwald-Stadler M, Promintzer M, Prager G, Mandl M, Nowotny P, Bischof MG, Wolzt M, Ludvik B, Kästenbauer T, Pacini G, Luger A, Krebs M.
    Diabetes Care; 2007 Sep 17; 30(9):2374-80. PubMed ID: 17595351
    [Abstract] [Full Text] [Related]

  • 16. Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3] insulin.
    Nanjo K, Sanke T, Miyano M, Okai K, Sowa R, Kondo M, Nishimura S, Iwo K, Miyamura K, Given BD.
    J Clin Invest; 1986 Feb 17; 77(2):514-9. PubMed ID: 3511099
    [Abstract] [Full Text] [Related]

  • 17. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
    Garvey WT, Olefsky JM, Rubenstein AH, Kolterman OG.
    Diabetes; 1988 May 17; 37(5):590-9. PubMed ID: 3282946
    [Abstract] [Full Text] [Related]

  • 18. Diabetes with mitochondrial gene tRNALYS mutation.
    Suzuki S, Hinokio Y, Hirai S, Onoda M, Matsumoto M, Ohtomo M, Kawasaki H, Satoh Y, Akai H, Abe K.
    Diabetes Care; 1994 Dec 17; 17(12):1428-32. PubMed ID: 7882812
    [Abstract] [Full Text] [Related]

  • 19. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
    Amoah AG, Owusu SK, Schuster DP, Osei K.
    S Afr Med J; 2002 May 17; 92(5):377-84. PubMed ID: 12108171
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.